Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-23-001049
Filing Date
2023-05-12
Accepted
2023-05-12 16:57:38
Documents
78
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q lsfp_10q.htm   iXBRL 10-Q 1004781
2 CERTIFICATION lsfp_ex311.htm EX-31.1 9203
3 CERTIFICATION lsfp_ex312.htm EX-31.2 9254
4 CERTIFICATION lsfp_ex321.htm EX-32.1 3466
5 CERTIFICATION lsfp_ex322.htm EX-32.2 3660
6 PRESS RELEASE lsfp_ex991.htm EX-99.1 16969
  Complete submission text file 0001096906-23-001049.txt   6093303

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA lsfp-20230331.xsd EX-101.SCH 74282
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lsfp-20230331_lab.xml EX-101.LAB 377450
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lsfp-20230331_cal.xml EX-101.CAL 61145
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lsfp-20230331_pre.xml EX-101.PRE 328924
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lsfp-20230331_def.xml EX-101.DEF 188043
72 EXTRACTED XBRL INSTANCE DOCUMENT lsfp_10q_htm.xml XML 963765
Mailing Address 4227 HABANA AVENUE JACKSONVILLE FL 32217
Business Address 4227 HABANA AVENUE JACKSONVILLE FL 32217 8479152446
LFTD PARTNERS INC. (Filer) CIK: 0001391135 (see all company filings)

EIN.: 870479286 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52520 | Film No.: 23916769
SIC: 2834 Pharmaceutical Preparations